PRESS RELEASE published on 04/28/2025 at 07:30, 1 year 4 months ago Exosens delivers strong revenue growth in Q1 2025 in a dynamic defense market environment; Fully on track to 2025 guidance Exosens reports strong revenue growth of 21.1% to €104.9m in Q1 2025 in the defense market. Adjusted gross margin up 28.1% to €52.6m, fully on track to 2025 guidance Revenue Growth Exosens Defense Market 2025 Guidance Adjusted Gross Margin
BRIEF published on 03/20/2025 at 07:35, 1 year 5 months ago Exosens joins the SBF 120 index Euronext Paris Investors Technology Exosens SBF 120
BRIEF published on 03/20/2025 at 07:35, 1 year 5 months ago Exosens rejoint l'indice SBF 120 Technologie Euronext Paris Investisseurs Exosens SBF 120
PRESS RELEASE published on 03/20/2025 at 07:30, 1 year 5 months ago EXOSENS JOINS THE SBF 120 INDEX Exosens, a high-tech company specializing in amplification, detection, and imaging technology, will join the SBF 120 index on 24 March 2025. This move marks a significant milestone post their IPO, enhancing visibility and investor appeal IPO Exosens Investor Appeal SBF 120 Index Amplification Technology
PRESS RELEASE published on 03/20/2025 at 07:30, 1 year 5 months ago EXOSENS INTÈGRE L’INDICE SBF 120 Exosens intègre l'indice SBF 120 en raison de sa croissance et de son leadership technologique dans les domaines de l'amplification, de la détection, et de l'imagerie. La société renforce ainsi sa visibilité et sa liquidité sur les marchés financiers Euronext Paris Liquidité Exosens SBF 120 Technologies Critiques
BRIEF published on 03/03/2025 at 07:36, 1 year 6 months ago Exosens Investit dans la Production de Vision Nocturne aux États-Unis Investissement Exosens États-Unis Vision Nocturne Marché Défense
BRIEF published on 03/03/2025 at 07:36, 1 year 6 months ago Exosens Invests in Night Vision Production in the United States Investment Exosens United States Defense Market Night Vision
BRIEF published on 03/03/2025 at 07:35, 1 year 6 months ago Exosens publie de solides résultats financiers pour l'exercice 2024 et dépasse les objectifs d'introduction en bourse Rentabilité Croissance Des Revenus Expansion De La Production Marché De La Défense Conseils Sur Les Introductions En Bourse
BRIEF published on 03/03/2025 at 07:35, 1 year 6 months ago Exosens Reports Robust FY 2024 Financial Results, Surpasses IPO Targets Revenue Growth Profitability Production Expansion Defense Market IPO Guidance
PRESS RELEASE published on 03/03/2025 at 07:31, 1 year 6 months ago Exosens makes first US investment in night vision production capacity to address growing demand and benefit from new opportunities Exosens to invest €20M in first US manufacturing site for night vision production, capturing larger market share and benefiting from growing demand Investment Exosens Production Capacity Market Demand Night Vision
Published on 09/11/2026 at 17:00, 1 hour 53 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 1 hour 53 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 3 hours 28 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 3 hours 53 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 4 hours 23 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 18:15, 38 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 53 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 18:00, 53 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 11 hours 53 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 11 hours 53 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 11 hours 53 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 11 hours 53 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 23 hours 23 minutes ago Availability of the 2026 Interim Financial Report
